nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1B1—Mitoxantrone—sarcoma	0.197	0.422	CbGbCtD
Melatonin—CYP1A1—Dacarbazine—sarcoma	0.111	0.238	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—sarcoma	0.0847	0.181	CbGbCtD
Melatonin—CYP1A2—Dacarbazine—sarcoma	0.0497	0.107	CbGbCtD
Melatonin—CYP1A2—Etoposide—sarcoma	0.0243	0.0521	CbGbCtD
Melatonin—EPX—hematopoietic system—sarcoma	0.00626	0.0375	CbGeAlD
Melatonin—IDO1—hematopoietic system—sarcoma	0.00475	0.0284	CbGeAlD
Melatonin—ESR1—periosteum—sarcoma	0.00474	0.0284	CbGeAlD
Melatonin—IDO1—connective tissue—sarcoma	0.00457	0.0273	CbGeAlD
Melatonin—CALR—mammary gland—sarcoma	0.00457	0.0273	CbGeAlD
Melatonin—EPX—lymphoid tissue—sarcoma	0.00441	0.0264	CbGeAlD
Melatonin—MTNR1A—hematopoietic system—sarcoma	0.00421	0.0252	CbGeAlD
Melatonin—EPX—bone marrow—sarcoma	0.00401	0.024	CbGeAlD
Melatonin—IDO1—lymphoid tissue—sarcoma	0.00334	0.02	CbGeAlD
Melatonin—CALR—myometrium—sarcoma	0.00324	0.0194	CbGeAlD
Melatonin—CALR—embryo—sarcoma	0.00312	0.0187	CbGeAlD
Melatonin—CALR—seminal vesicle—sarcoma	0.00293	0.0175	CbGeAlD
Melatonin—ASMT—testis—sarcoma	0.00284	0.017	CbGeAlD
Melatonin—CALR—hematopoietic system—sarcoma	0.00278	0.0167	CbGeAlD
Melatonin—CALR—connective tissue—sarcoma	0.00268	0.016	CbGeAlD
Melatonin—MPO—endothelium—sarcoma	0.00246	0.0147	CbGeAlD
Melatonin—CALR—smooth muscle tissue—sarcoma	0.00245	0.0147	CbGeAlD
Melatonin—CALR—skin of body—sarcoma	0.00242	0.0145	CbGeAlD
Melatonin—MTNR1A—testis—sarcoma	0.00231	0.0138	CbGeAlD
Melatonin—CALR—cardiac atrium—sarcoma	0.00211	0.0126	CbGeAlD
Melatonin—CALR—uterus—sarcoma	0.0021	0.0126	CbGeAlD
Melatonin—CALR—lymphoid tissue—sarcoma	0.00196	0.0117	CbGeAlD
Melatonin—MT3—testis—sarcoma	0.00193	0.0116	CbGeAlD
Melatonin—IDO1—lymph node—sarcoma	0.00188	0.0113	CbGeAlD
Melatonin—CALR—tendon—sarcoma	0.00184	0.011	CbGeAlD
Melatonin—NQO2—myometrium—sarcoma	0.00183	0.0109	CbGeAlD
Melatonin—CALR—bone marrow—sarcoma	0.00178	0.0107	CbGeAlD
Melatonin—CALM3—mammary gland—sarcoma	0.00178	0.0107	CbGeAlD
Melatonin—CALM2—endothelium—sarcoma	0.00174	0.0104	CbGeAlD
Melatonin—CALM1—endothelium—sarcoma	0.00173	0.0103	CbGeAlD
Melatonin—NQO2—seminal vesicle—sarcoma	0.00165	0.00988	CbGeAlD
Melatonin—CALR—testis—sarcoma	0.00152	0.00913	CbGeAlD
Melatonin—CYP1B1—mammary gland—sarcoma	0.00151	0.00906	CbGeAlD
Melatonin—CALR—liver—sarcoma	0.00144	0.00863	CbGeAlD
Melatonin—ESR1—mammary gland—sarcoma	0.00141	0.00843	CbGeAlD
Melatonin—MT3—lymph node—sarcoma	0.0014	0.00839	CbGeAlD
Melatonin—CALM1—mammary gland—sarcoma	0.00139	0.00834	CbGeAlD
Melatonin—CALM3—myometrium—sarcoma	0.00126	0.00757	CbGeAlD
Melatonin—MPO—hematopoietic system—sarcoma	0.00121	0.00723	CbGeAlD
Melatonin—NQO2—cardiac atrium—sarcoma	0.00119	0.00713	CbGeAlD
Melatonin—NQO2—uterus—sarcoma	0.00119	0.0071	CbGeAlD
Melatonin—MPO—connective tissue—sarcoma	0.00116	0.00696	CbGeAlD
Melatonin—CALM3—seminal vesicle—sarcoma	0.00114	0.00684	CbGeAlD
Melatonin—CALR—lymph node—sarcoma	0.00111	0.00661	CbGeAlD
Melatonin—MPO—skin of body—sarcoma	0.00105	0.00629	CbGeAlD
Melatonin—NQO2—tendon—sarcoma	0.00104	0.00622	CbGeAlD
Melatonin—CYP2C9—mammary gland—sarcoma	0.00103	0.00617	CbGeAlD
Melatonin—NQO2—bone marrow—sarcoma	0.00101	0.00602	CbGeAlD
Melatonin—ESR1—myometrium—sarcoma	0.000999	0.00598	CbGeAlD
Melatonin—CALM2—myometrium—sarcoma	0.000993	0.00594	CbGeAlD
Melatonin—CALM1—myometrium—sarcoma	0.000988	0.00592	CbGeAlD
Melatonin—CYP19A1—hematopoietic system—sarcoma	0.000987	0.00591	CbGeAlD
Melatonin—SLC22A8—hematopoietic system—sarcoma	0.000965	0.00578	CbGeAlD
Melatonin—ESR1—embryo—sarcoma	0.000961	0.00575	CbGeAlD
Melatonin—CALM3—smooth muscle tissue—sarcoma	0.000956	0.00572	CbGeAlD
Melatonin—CALM2—embryo—sarcoma	0.000955	0.00572	CbGeAlD
Melatonin—CALM1—embryo—sarcoma	0.000951	0.00569	CbGeAlD
Melatonin—CYP19A1—connective tissue—sarcoma	0.00095	0.00569	CbGeAlD
Melatonin—CYP1B1—hematopoietic system—sarcoma	0.000923	0.00552	CbGeAlD
Melatonin—CALM2—seminal vesicle—sarcoma	0.000897	0.00537	CbGeAlD
Melatonin—CYP1B1—connective tissue—sarcoma	0.000888	0.00532	CbGeAlD
Melatonin—NQO2—testis—sarcoma	0.00086	0.00515	CbGeAlD
Melatonin—ESR1—hematopoietic system—sarcoma	0.000858	0.00513	CbGeAlD
Melatonin—CALM2—hematopoietic system—sarcoma	0.000852	0.0051	CbGeAlD
Melatonin—MPO—lymphoid tissue—sarcoma	0.00085	0.00509	CbGeAlD
Melatonin—CALM1—hematopoietic system—sarcoma	0.000849	0.00508	CbGeAlD
Melatonin—ESR1—connective tissue—sarcoma	0.000826	0.00494	CbGeAlD
Melatonin—CALM3—cardiac atrium—sarcoma	0.000824	0.00493	CbGeAlD
Melatonin—CALM2—connective tissue—sarcoma	0.000821	0.00491	CbGeAlD
Melatonin—CALM3—uterus—sarcoma	0.00082	0.00491	CbGeAlD
Melatonin—CALM1—connective tissue—sarcoma	0.000817	0.00489	CbGeAlD
Melatonin—NQO2—liver—sarcoma	0.000813	0.00487	CbGeAlD
Melatonin—CYP1B1—smooth muscle tissue—sarcoma	0.000813	0.00486	CbGeAlD
Melatonin—CYP2C19—hematopoietic system—sarcoma	0.000809	0.00485	CbGeAlD
Melatonin—CYP1B1—skin of body—sarcoma	0.000802	0.0048	CbGeAlD
Melatonin—MPO—bone marrow—sarcoma	0.000774	0.00463	CbGeAlD
Melatonin—ESR1—smooth muscle tissue—sarcoma	0.000755	0.00452	CbGeAlD
Melatonin—CALM2—smooth muscle tissue—sarcoma	0.000751	0.00449	CbGeAlD
Melatonin—CALM1—smooth muscle tissue—sarcoma	0.000747	0.00447	CbGeAlD
Melatonin—CYP19A1—uterus—sarcoma	0.000745	0.00446	CbGeAlD
Melatonin—CALM2—skin of body—sarcoma	0.000741	0.00444	CbGeAlD
Melatonin—CALM1—skin of body—sarcoma	0.000738	0.00442	CbGeAlD
Melatonin—CALM3—tendon—sarcoma	0.000718	0.0043	CbGeAlD
Melatonin—CYP1B1—uterus—sarcoma	0.000697	0.00417	CbGeAlD
Melatonin—CALM3—bone marrow—sarcoma	0.000696	0.00417	CbGeAlD
Melatonin—MPO—testis—sarcoma	0.000662	0.00396	CbGeAlD
Melatonin—CYP1A2—hematopoietic system—sarcoma	0.000661	0.00396	CbGeAlD
Melatonin—CYP1A1—hematopoietic system—sarcoma	0.000652	0.0039	CbGeAlD
Melatonin—CYP1B1—lymphoid tissue—sarcoma	0.000649	0.00389	CbGeAlD
Melatonin—ESR1—uterus—sarcoma	0.000648	0.00388	CbGeAlD
Melatonin—CALM2—cardiac atrium—sarcoma	0.000647	0.00387	CbGeAlD
Melatonin—CALM1—cardiac atrium—sarcoma	0.000644	0.00386	CbGeAlD
Melatonin—CALM2—uterus—sarcoma	0.000644	0.00385	CbGeAlD
Melatonin—CALM1—uterus—sarcoma	0.000641	0.00384	CbGeAlD
Melatonin—CYP2C9—hematopoietic system—sarcoma	0.000628	0.00376	CbGeAlD
Melatonin—MPO—liver—sarcoma	0.000626	0.00375	CbGeAlD
Melatonin—NQO2—lymph node—sarcoma	0.000623	0.00373	CbGeAlD
Melatonin—CYP1B1—tendon—sarcoma	0.000611	0.00365	CbGeAlD
Melatonin—ESR1—lymphoid tissue—sarcoma	0.000604	0.00361	CbGeAlD
Melatonin—CALM2—lymphoid tissue—sarcoma	0.0006	0.00359	CbGeAlD
Melatonin—CALM1—lymphoid tissue—sarcoma	0.000597	0.00358	CbGeAlD
Melatonin—CALM3—testis—sarcoma	0.000595	0.00356	CbGeAlD
Melatonin—CYP1A1—skin of body—sarcoma	0.000567	0.00339	CbGeAlD
Melatonin—CALM2—tendon—sarcoma	0.000564	0.00338	CbGeAlD
Melatonin—CALM3—liver—sarcoma	0.000562	0.00337	CbGeAlD
Melatonin—CALM1—tendon—sarcoma	0.000562	0.00336	CbGeAlD
Melatonin—CALM2—bone marrow—sarcoma	0.000546	0.00327	CbGeAlD
Melatonin—CALM1—bone marrow—sarcoma	0.000544	0.00326	CbGeAlD
Melatonin—CYP19A1—testis—sarcoma	0.000541	0.00324	CbGeAlD
Melatonin—CYP19A1—liver—sarcoma	0.000511	0.00306	CbGeAlD
Melatonin—CYP1B1—testis—sarcoma	0.000506	0.00303	CbGeAlD
Melatonin—CYP1A1—cardiac atrium—sarcoma	0.000495	0.00296	CbGeAlD
Melatonin—CYP1A1—uterus—sarcoma	0.000493	0.00295	CbGeAlD
Melatonin—MPO—lymph node—sarcoma	0.00048	0.00287	CbGeAlD
Melatonin—CYP1B1—liver—sarcoma	0.000478	0.00286	CbGeAlD
Melatonin—ESR1—testis—sarcoma	0.00047	0.00281	CbGeAlD
Melatonin—Mouth ulceration—Doxorubicin—sarcoma	0.000468	0.00319	CcSEcCtD
Melatonin—CALM2—testis—sarcoma	0.000467	0.0028	CbGeAlD
Melatonin—CALM1—testis—sarcoma	0.000465	0.00278	CbGeAlD
Melatonin—Cardiac disorder—Etoposide—sarcoma	0.000465	0.00317	CcSEcCtD
Melatonin—Hypertension—Vincristine—sarcoma	0.000465	0.00317	CcSEcCtD
Melatonin—Angiopathy—Etoposide—sarcoma	0.000454	0.0031	CcSEcCtD
Melatonin—Hypertension—Mitoxantrone—sarcoma	0.000453	0.00309	CcSEcCtD
Melatonin—Immune system disorder—Etoposide—sarcoma	0.000452	0.00309	CcSEcCtD
Melatonin—Eczema—Epirubicin—sarcoma	0.000452	0.00308	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000451	0.00308	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000448	0.00305	CcSEcCtD
Melatonin—Chest pain—Mitoxantrone—sarcoma	0.000446	0.00304	CcSEcCtD
Melatonin—Arthralgia—Mitoxantrone—sarcoma	0.000446	0.00304	CcSEcCtD
Melatonin—Paraesthesia—Thiotepa—sarcoma	0.000445	0.00303	CcSEcCtD
Melatonin—Anxiety—Mitoxantrone—sarcoma	0.000445	0.00303	CcSEcCtD
Melatonin—ESR1—liver—sarcoma	0.000444	0.00266	CbGeAlD
Melatonin—CALM2—liver—sarcoma	0.000442	0.00264	CbGeAlD
Melatonin—Somnolence—Thiotepa—sarcoma	0.00044	0.003	CcSEcCtD
Melatonin—CALM1—liver—sarcoma	0.00044	0.00263	CbGeAlD
Melatonin—Infection—Vincristine—sarcoma	0.000436	0.00298	CcSEcCtD
Melatonin—Dyspepsia—Thiotepa—sarcoma	0.000436	0.00297	CcSEcCtD
Melatonin—Hot flush—Epirubicin—sarcoma	0.000434	0.00296	CcSEcCtD
Melatonin—CALM3—lymph node—sarcoma	0.000431	0.00258	CbGeAlD
Melatonin—Nervous system disorder—Vincristine—sarcoma	0.000431	0.00294	CcSEcCtD
Melatonin—Menopausal symptoms—Epirubicin—sarcoma	0.00043	0.00293	CcSEcCtD
Melatonin—Thrombocytopenia—Vincristine—sarcoma	0.00043	0.00293	CcSEcCtD
Melatonin—Gastrointestinal disorder—Thiotepa—sarcoma	0.000428	0.00292	CcSEcCtD
Melatonin—Fatigue—Thiotepa—sarcoma	0.000427	0.00291	CcSEcCtD
Melatonin—Infection—Mitoxantrone—sarcoma	0.000425	0.0029	CcSEcCtD
Melatonin—Fatigue—Dactinomycin—sarcoma	0.000424	0.00289	CcSEcCtD
Melatonin—Pain—Thiotepa—sarcoma	0.000424	0.00289	CcSEcCtD
Melatonin—Back pain—Etoposide—sarcoma	0.000422	0.00288	CcSEcCtD
Melatonin—Shock—Mitoxantrone—sarcoma	0.000421	0.00287	CcSEcCtD
Melatonin—Pain—Dactinomycin—sarcoma	0.00042	0.00287	CcSEcCtD
Melatonin—CYP2C19—liver—sarcoma	0.000419	0.00251	CbGeAlD
Melatonin—Muscle spasms—Etoposide—sarcoma	0.000419	0.00286	CcSEcCtD
Melatonin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000419	0.00286	CcSEcCtD
Melatonin—Eczema—Doxorubicin—sarcoma	0.000418	0.00285	CcSEcCtD
Melatonin—Skin disorder—Mitoxantrone—sarcoma	0.000416	0.00283	CcSEcCtD
Melatonin—Lethargy—Epirubicin—sarcoma	0.000414	0.00282	CcSEcCtD
Melatonin—Hyponatraemia—Epirubicin—sarcoma	0.000407	0.00278	CcSEcCtD
Melatonin—Pain in extremity—Epirubicin—sarcoma	0.000406	0.00277	CcSEcCtD
Melatonin—Gastrointestinal pain—Thiotepa—sarcoma	0.000405	0.00276	CcSEcCtD
Melatonin—Gastrointestinal pain—Dactinomycin—sarcoma	0.000402	0.00274	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—sarcoma	0.000401	0.00274	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Vincristine—sarcoma	0.0004	0.00273	CcSEcCtD
Melatonin—Affect lability—Epirubicin—sarcoma	0.000399	0.00272	CcSEcCtD
Melatonin—Migraine—Epirubicin—sarcoma	0.000399	0.00272	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—sarcoma	0.000398	0.00271	CcSEcCtD
Melatonin—Insomnia—Vincristine—sarcoma	0.000397	0.00271	CcSEcCtD
Melatonin—Paraesthesia—Vincristine—sarcoma	0.000394	0.00269	CcSEcCtD
Melatonin—CYP19A1—lymph node—sarcoma	0.000392	0.00235	CbGeAlD
Melatonin—Vertigo—Etoposide—sarcoma	0.000392	0.00267	CcSEcCtD
Melatonin—Abdominal pain—Thiotepa—sarcoma	0.000392	0.00267	CcSEcCtD
Melatonin—Leukopenia—Etoposide—sarcoma	0.00039	0.00266	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00039	0.00266	CcSEcCtD
Melatonin—Abdominal pain—Dactinomycin—sarcoma	0.000389	0.00265	CcSEcCtD
Melatonin—Mood swings—Epirubicin—sarcoma	0.000384	0.00262	CcSEcCtD
Melatonin—Paraesthesia—Mitoxantrone—sarcoma	0.000384	0.00262	CcSEcCtD
Melatonin—Loss of consciousness—Etoposide—sarcoma	0.000383	0.00261	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—sarcoma	0.000383	0.00261	CcSEcCtD
Melatonin—Somnolence—Mitoxantrone—sarcoma	0.00038	0.00259	CcSEcCtD
Melatonin—Gastrointestinal disorder—Vincristine—sarcoma	0.000379	0.00259	CcSEcCtD
Melatonin—Fatigue—Vincristine—sarcoma	0.000379	0.00258	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—sarcoma	0.000377	0.00257	CcSEcCtD
Melatonin—Dyspepsia—Mitoxantrone—sarcoma	0.000377	0.00257	CcSEcCtD
Melatonin—Hypertension—Etoposide—sarcoma	0.000376	0.00257	CcSEcCtD
Melatonin—Pain—Vincristine—sarcoma	0.000376	0.00256	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—sarcoma	0.000376	0.00256	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—sarcoma	0.000375	0.00256	CcSEcCtD
Melatonin—Dry skin—Epirubicin—sarcoma	0.000372	0.00254	CcSEcCtD
Melatonin—Chest pain—Etoposide—sarcoma	0.000371	0.00253	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—sarcoma	0.000371	0.00253	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—sarcoma	0.00037	0.00252	CcSEcCtD
Melatonin—Migraine—Doxorubicin—sarcoma	0.00037	0.00252	CcSEcCtD
Melatonin—Fatigue—Mitoxantrone—sarcoma	0.000369	0.00252	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000369	0.00251	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—sarcoma	0.000367	0.0025	CcSEcCtD
Melatonin—CYP1B1—lymph node—sarcoma	0.000366	0.00219	CbGeAlD
Melatonin—Pain—Mitoxantrone—sarcoma	0.000366	0.00249	CcSEcCtD
Melatonin—Hypersensitivity—Thiotepa—sarcoma	0.000365	0.00249	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—sarcoma	0.000363	0.00247	CcSEcCtD
Melatonin—Hypersensitivity—Dactinomycin—sarcoma	0.000362	0.00247	CcSEcCtD
Melatonin—Gastrointestinal pain—Vincristine—sarcoma	0.000359	0.00245	CcSEcCtD
Melatonin—Gastritis—Epirubicin—sarcoma	0.000359	0.00245	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—sarcoma	0.000356	0.00243	CcSEcCtD
Melatonin—Asthenia—Thiotepa—sarcoma	0.000355	0.00242	CcSEcCtD
Melatonin—Infection—Etoposide—sarcoma	0.000354	0.00241	CcSEcCtD
Melatonin—Asthenia—Dactinomycin—sarcoma	0.000353	0.00241	CcSEcCtD
Melatonin—Pruritus—Thiotepa—sarcoma	0.00035	0.00239	CcSEcCtD
Melatonin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00035	0.00239	CcSEcCtD
Melatonin—Thrombocytopenia—Etoposide—sarcoma	0.000348	0.00238	CcSEcCtD
Melatonin—Abdominal pain—Vincristine—sarcoma	0.000347	0.00237	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—sarcoma	0.000347	0.00236	CcSEcCtD
Melatonin—Skin disorder—Etoposide—sarcoma	0.000346	0.00236	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—sarcoma	0.000344	0.00235	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—sarcoma	0.000343	0.00234	CcSEcCtD
Melatonin—CYP1A2—liver—sarcoma	0.000343	0.00205	CbGeAlD
Melatonin—Angina pectoris—Epirubicin—sarcoma	0.000342	0.00233	CcSEcCtD
Melatonin—ESR1—lymph node—sarcoma	0.000341	0.00204	CbGeAlD
Melatonin—Breast disorder—Doxorubicin—sarcoma	0.000339	0.00231	CcSEcCtD
Melatonin—CALM2—lymph node—sarcoma	0.000339	0.00203	CbGeAlD
Melatonin—Abdominal pain—Mitoxantrone—sarcoma	0.000338	0.00231	CcSEcCtD
Melatonin—CYP1A1—liver—sarcoma	0.000338	0.00202	CbGeAlD
Melatonin—CALM1—lymph node—sarcoma	0.000337	0.00202	CbGeAlD
Melatonin—Nasopharyngitis—Doxorubicin—sarcoma	0.000336	0.00229	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—sarcoma	0.000332	0.00227	CcSEcCtD
Melatonin—Dizziness—Thiotepa—sarcoma	0.000328	0.00223	CcSEcCtD
Melatonin—CYP2C9—liver—sarcoma	0.000325	0.00195	CbGeAlD
Melatonin—Hypersensitivity—Vincristine—sarcoma	0.000324	0.00221	CcSEcCtD
Melatonin—Paraesthesia—Etoposide—sarcoma	0.00032	0.00218	CcSEcCtD
Melatonin—Weight increased—Epirubicin—sarcoma	0.000319	0.00218	CcSEcCtD
Melatonin—Somnolence—Etoposide—sarcoma	0.000316	0.00216	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—sarcoma	0.000316	0.00216	CcSEcCtD
Melatonin—Hypersensitivity—Mitoxantrone—sarcoma	0.000315	0.00215	CcSEcCtD
Melatonin—Asthenia—Vincristine—sarcoma	0.000315	0.00215	CcSEcCtD
Melatonin—Vomiting—Thiotepa—sarcoma	0.000315	0.00215	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—sarcoma	0.000313	0.00213	CcSEcCtD
Melatonin—Infestation—Epirubicin—sarcoma	0.000313	0.00213	CcSEcCtD
Melatonin—Vomiting—Dactinomycin—sarcoma	0.000313	0.00213	CcSEcCtD
Melatonin—Rash—Thiotepa—sarcoma	0.000312	0.00213	CcSEcCtD
Melatonin—Dermatitis—Thiotepa—sarcoma	0.000312	0.00213	CcSEcCtD
Melatonin—Headache—Thiotepa—sarcoma	0.00031	0.00212	CcSEcCtD
Melatonin—Rash—Dactinomycin—sarcoma	0.00031	0.00211	CcSEcCtD
Melatonin—Gastrointestinal disorder—Etoposide—sarcoma	0.000307	0.0021	CcSEcCtD
Melatonin—Asthenia—Mitoxantrone—sarcoma	0.000307	0.00209	CcSEcCtD
Melatonin—Fatigue—Etoposide—sarcoma	0.000307	0.00209	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—sarcoma	0.000305	0.00208	CcSEcCtD
Melatonin—Pain—Etoposide—sarcoma	0.000304	0.00208	CcSEcCtD
Melatonin—Haematuria—Epirubicin—sarcoma	0.000298	0.00203	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—sarcoma	0.000296	0.00202	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—sarcoma	0.000295	0.00201	CcSEcCtD
Melatonin—Nausea—Thiotepa—sarcoma	0.000294	0.00201	CcSEcCtD
Melatonin—Nausea—Dactinomycin—sarcoma	0.000292	0.00199	CcSEcCtD
Melatonin—Gastrointestinal pain—Etoposide—sarcoma	0.000291	0.00198	CcSEcCtD
Melatonin—Dizziness—Vincristine—sarcoma	0.00029	0.00198	CcSEcCtD
Melatonin—Infestation—Doxorubicin—sarcoma	0.000289	0.00197	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—sarcoma	0.000289	0.00197	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—sarcoma	0.000282	0.00192	CcSEcCtD
Melatonin—Abdominal pain—Etoposide—sarcoma	0.000281	0.00192	CcSEcCtD
Melatonin—Vomiting—Vincristine—sarcoma	0.000279	0.0019	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—sarcoma	0.000277	0.00189	CcSEcCtD
Melatonin—Rash—Vincristine—sarcoma	0.000277	0.00189	CcSEcCtD
Melatonin—Dermatitis—Vincristine—sarcoma	0.000277	0.00189	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—sarcoma	0.000276	0.00188	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—sarcoma	0.000276	0.00188	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—sarcoma	0.000275	0.00188	CcSEcCtD
Melatonin—Headache—Vincristine—sarcoma	0.000275	0.00188	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000274	0.00187	CcSEcCtD
Melatonin—Vomiting—Mitoxantrone—sarcoma	0.000272	0.00185	CcSEcCtD
Melatonin—Rash—Mitoxantrone—sarcoma	0.00027	0.00184	CcSEcCtD
Melatonin—Dermatitis—Mitoxantrone—sarcoma	0.000269	0.00184	CcSEcCtD
Melatonin—Headache—Mitoxantrone—sarcoma	0.000268	0.00183	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—sarcoma	0.000262	0.00179	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—sarcoma	0.000262	0.00179	CcSEcCtD
Melatonin—Nausea—Vincristine—sarcoma	0.000261	0.00178	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—sarcoma	0.000261	0.00178	CcSEcCtD
Melatonin—CYP1A1—lymph node—sarcoma	0.000259	0.00155	CbGeAlD
Melatonin—Urinary tract disorder—Doxorubicin—sarcoma	0.000257	0.00175	CcSEcCtD
Melatonin—Asthenia—Etoposide—sarcoma	0.000255	0.00174	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—sarcoma	0.000255	0.00174	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—sarcoma	0.000255	0.00174	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—sarcoma	0.000255	0.00174	CcSEcCtD
Melatonin—Nausea—Mitoxantrone—sarcoma	0.000254	0.00173	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—sarcoma	0.000254	0.00173	CcSEcCtD
Melatonin—Pruritus—Etoposide—sarcoma	0.000252	0.00172	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—sarcoma	0.000246	0.00168	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—sarcoma	0.000244	0.00167	CcSEcCtD
Melatonin—Erythema—Epirubicin—sarcoma	0.000244	0.00167	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—sarcoma	0.000243	0.00166	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—sarcoma	0.000241	0.00164	CcSEcCtD
Melatonin—Flatulence—Epirubicin—sarcoma	0.000241	0.00164	CcSEcCtD
Melatonin—Tension—Epirubicin—sarcoma	0.00024	0.00164	CcSEcCtD
Melatonin—Nervousness—Epirubicin—sarcoma	0.000237	0.00162	CcSEcCtD
Melatonin—Back pain—Epirubicin—sarcoma	0.000236	0.00161	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—sarcoma	0.000236	0.00161	CcSEcCtD
Melatonin—Dizziness—Etoposide—sarcoma	0.000235	0.0016	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—sarcoma	0.000235	0.0016	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—sarcoma	0.000235	0.0016	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—sarcoma	0.00023	0.00157	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—sarcoma	0.000228	0.00155	CcSEcCtD
Melatonin—Vomiting—Etoposide—sarcoma	0.000226	0.00154	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—sarcoma	0.000226	0.00154	CcSEcCtD
Melatonin—Erythema—Doxorubicin—sarcoma	0.000226	0.00154	CcSEcCtD
Melatonin—Agitation—Epirubicin—sarcoma	0.000225	0.00153	CcSEcCtD
Melatonin—Rash—Etoposide—sarcoma	0.000224	0.00153	CcSEcCtD
Melatonin—Dermatitis—Etoposide—sarcoma	0.000224	0.00153	CcSEcCtD
Melatonin—Headache—Etoposide—sarcoma	0.000223	0.00152	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—sarcoma	0.000223	0.00152	CcSEcCtD
Melatonin—Tension—Doxorubicin—sarcoma	0.000222	0.00151	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—sarcoma	0.00022	0.0015	CcSEcCtD
Melatonin—Vertigo—Epirubicin—sarcoma	0.00022	0.0015	CcSEcCtD
Melatonin—Syncope—Epirubicin—sarcoma	0.000219	0.00149	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—sarcoma	0.000219	0.00149	CcSEcCtD
Melatonin—Back pain—Doxorubicin—sarcoma	0.000219	0.00149	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—sarcoma	0.000217	0.00148	CcSEcCtD
Melatonin—Palpitations—Epirubicin—sarcoma	0.000216	0.00147	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—sarcoma	0.000215	0.00146	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—sarcoma	0.000213	0.00145	CcSEcCtD
Melatonin—Nausea—Etoposide—sarcoma	0.000211	0.00144	CcSEcCtD
Melatonin—Hypertension—Epirubicin—sarcoma	0.000211	0.00144	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—sarcoma	0.000208	0.00142	CcSEcCtD
Melatonin—Chest pain—Epirubicin—sarcoma	0.000208	0.00142	CcSEcCtD
Melatonin—Agitation—Doxorubicin—sarcoma	0.000208	0.00142	CcSEcCtD
Melatonin—Anxiety—Epirubicin—sarcoma	0.000207	0.00141	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000207	0.00141	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—sarcoma	0.000203	0.00139	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—sarcoma	0.000203	0.00139	CcSEcCtD
Melatonin—Syncope—Doxorubicin—sarcoma	0.000203	0.00138	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—sarcoma	0.000202	0.00138	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—sarcoma	0.0002	0.00136	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—sarcoma	0.000199	0.00136	CcSEcCtD
Melatonin—Infection—Epirubicin—sarcoma	0.000198	0.00135	CcSEcCtD
Melatonin—Shock—Epirubicin—sarcoma	0.000196	0.00134	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—sarcoma	0.000196	0.00133	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—sarcoma	0.000195	0.00133	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—sarcoma	0.000195	0.00133	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—sarcoma	0.000194	0.00132	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—sarcoma	0.000193	0.00131	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—sarcoma	0.000193	0.00131	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—sarcoma	0.000192	0.00131	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000191	0.0013	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—sarcoma	0.000188	0.00128	CcSEcCtD
Melatonin—Infection—Doxorubicin—sarcoma	0.000183	0.00125	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000182	0.00124	CcSEcCtD
Melatonin—Shock—Doxorubicin—sarcoma	0.000182	0.00124	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—sarcoma	0.000181	0.00123	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—sarcoma	0.000181	0.00123	CcSEcCtD
Melatonin—Insomnia—Epirubicin—sarcoma	0.00018	0.00123	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—sarcoma	0.000179	0.00122	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—sarcoma	0.000179	0.00122	CcSEcCtD
Melatonin—Somnolence—Epirubicin—sarcoma	0.000177	0.00121	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—sarcoma	0.000176	0.0012	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000172	0.00117	CcSEcCtD
Melatonin—Fatigue—Epirubicin—sarcoma	0.000172	0.00117	CcSEcCtD
Melatonin—Pain—Epirubicin—sarcoma	0.000171	0.00116	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000168	0.00115	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—sarcoma	0.000167	0.00114	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—sarcoma	0.000166	0.00113	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—sarcoma	0.000164	0.00112	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—sarcoma	0.000163	0.00111	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—sarcoma	0.000162	0.00111	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000159	0.00109	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—sarcoma	0.000159	0.00109	CcSEcCtD
Melatonin—Pain—Doxorubicin—sarcoma	0.000158	0.00108	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—sarcoma	0.000158	0.00108	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000151	0.00103	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—sarcoma	0.000147	0.001	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—sarcoma	0.000146	0.000995	CcSEcCtD
Melatonin—Asthenia—Epirubicin—sarcoma	0.000143	0.000976	CcSEcCtD
Melatonin—Pruritus—Epirubicin—sarcoma	0.000141	0.000962	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—sarcoma	0.000136	0.000927	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—sarcoma	0.000132	0.000903	CcSEcCtD
Melatonin—Dizziness—Epirubicin—sarcoma	0.000132	0.0009	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—sarcoma	0.000131	0.00089	CcSEcCtD
Melatonin—Vomiting—Epirubicin—sarcoma	0.000127	0.000865	CcSEcCtD
Melatonin—Rash—Epirubicin—sarcoma	0.000126	0.000858	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—sarcoma	0.000126	0.000857	CcSEcCtD
Melatonin—Headache—Epirubicin—sarcoma	0.000125	0.000852	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—sarcoma	0.000122	0.000832	CcSEcCtD
Melatonin—Nausea—Epirubicin—sarcoma	0.000118	0.000808	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—sarcoma	0.000117	0.0008	CcSEcCtD
Melatonin—Rash—Doxorubicin—sarcoma	0.000116	0.000794	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—sarcoma	0.000116	0.000793	CcSEcCtD
Melatonin—Headache—Doxorubicin—sarcoma	0.000116	0.000788	CcSEcCtD
Melatonin—Nausea—Doxorubicin—sarcoma	0.00011	0.000748	CcSEcCtD
Melatonin—CALM2—Immune System—PDGFRB—sarcoma	2.21e-05	0.000101	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—HRAS—sarcoma	2.19e-05	0.0001	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—HRAS—sarcoma	2.19e-05	0.0001	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—MDM2—sarcoma	2.19e-05	9.99e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—MDM2—sarcoma	2.19e-05	9.99e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PDGFRA—sarcoma	2.18e-05	9.92e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PDGFRA—sarcoma	2.18e-05	9.92e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FLT1—sarcoma	2.12e-05	9.68e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—FOXO1—sarcoma	2.12e-05	9.67e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PDGFRB—sarcoma	2.12e-05	9.65e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—FOXO1—sarcoma	2.11e-05	9.64e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PDGFRB—sarcoma	2.11e-05	9.62e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PLCG1—sarcoma	2.09e-05	9.51e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PDGFRA—sarcoma	2.08e-05	9.5e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ENO2—sarcoma	2.08e-05	9.49e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PDGFRA—sarcoma	2.08e-05	9.47e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—HBA1—sarcoma	2.07e-05	9.43e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FLT1—sarcoma	2.05e-05	9.36e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FLT1—sarcoma	2.05e-05	9.36e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—JUN—sarcoma	2.05e-05	9.35e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—FOXO1—sarcoma	2.04e-05	9.32e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—FOXO1—sarcoma	2.04e-05	9.32e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—SRC—sarcoma	2.04e-05	9.32e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PDGFRB—sarcoma	2.04e-05	9.31e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PDGFRB—sarcoma	2.04e-05	9.31e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CTNNB1—sarcoma	2.03e-05	9.28e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PLCG1—sarcoma	2.02e-05	9.2e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PLCG1—sarcoma	2.02e-05	9.2e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PDGFRA—sarcoma	2.01e-05	9.16e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PDGFRA—sarcoma	2.01e-05	9.16e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCR4—sarcoma	2e-05	9.14e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—VEGFA—sarcoma	1.99e-05	9.07e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—JUN—sarcoma	1.98e-05	9.04e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—JUN—sarcoma	1.98e-05	9.04e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ATF1—sarcoma	1.98e-05	9.04e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—SRC—sarcoma	1.98e-05	9.01e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—SRC—sarcoma	1.98e-05	9.01e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CTNNB1—sarcoma	1.97e-05	8.98e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CTNNB1—sarcoma	1.97e-05	8.98e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—NRAS—sarcoma	1.96e-05	8.96e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCR4—sarcoma	1.94e-05	8.84e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCR4—sarcoma	1.94e-05	8.84e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PLCG1—sarcoma	1.94e-05	8.83e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—VEGFA—sarcoma	1.92e-05	8.78e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—VEGFA—sarcoma	1.92e-05	8.78e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ATF1—sarcoma	1.92e-05	8.74e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ATF1—sarcoma	1.92e-05	8.74e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—NRAS—sarcoma	1.9e-05	8.67e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—NRAS—sarcoma	1.9e-05	8.67e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—SRC—sarcoma	1.84e-05	8.39e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—CREB1—sarcoma	1.82e-05	8.29e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—SRC—sarcoma	1.78e-05	8.11e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—SRC—sarcoma	1.78e-05	8.11e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ENO2—sarcoma	1.78e-05	8.11e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—NRAS—sarcoma	1.77e-05	8.07e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—HBA1—sarcoma	1.77e-05	8.06e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PLCG1—sarcoma	1.77e-05	8.05e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—SRC—sarcoma	1.77e-05	8.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CREB1—sarcoma	1.76e-05	8.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CREB1—sarcoma	1.76e-05	8.02e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KDR—sarcoma	1.75e-05	8e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KIT—sarcoma	1.74e-05	7.95e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—NRAS—sarcoma	1.71e-05	7.8e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—NRAS—sarcoma	1.71e-05	7.8e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—SRC—sarcoma	1.71e-05	7.79e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—SRC—sarcoma	1.71e-05	7.79e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—NRAS—sarcoma	1.7e-05	7.75e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—KRAS—sarcoma	1.69e-05	7.71e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KIT—sarcoma	1.69e-05	7.69e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KIT—sarcoma	1.69e-05	7.69e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CREB1—sarcoma	1.66e-05	7.57e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—NRAS—sarcoma	1.64e-05	7.49e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—NRAS—sarcoma	1.64e-05	7.49e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—KRAS—sarcoma	1.64e-05	7.46e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—KRAS—sarcoma	1.64e-05	7.46e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KIT—sarcoma	1.62e-05	7.37e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—EGFR—sarcoma	1.61e-05	7.35e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KIT—sarcoma	1.61e-05	7.34e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CREB1—sarcoma	1.61e-05	7.32e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CREB1—sarcoma	1.61e-05	7.32e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—EGFR—sarcoma	1.56e-05	7.11e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—EGFR—sarcoma	1.56e-05	7.11e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KIT—sarcoma	1.56e-05	7.1e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KIT—sarcoma	1.56e-05	7.1e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1R—sarcoma	1.55e-05	7.09e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—EGFR—sarcoma	1.55e-05	7.06e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CREB1—sarcoma	1.54e-05	7.01e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CREB1—sarcoma	1.53e-05	6.99e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KRAS—sarcoma	1.52e-05	6.94e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PLCG1—sarcoma	1.51e-05	6.88e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1R—sarcoma	1.5e-05	6.86e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1R—sarcoma	1.5e-05	6.86e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—sarcoma	1.5e-05	6.86e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—EGFR—sarcoma	1.5e-05	6.83e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—EGFR—sarcoma	1.5e-05	6.83e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CREB1—sarcoma	1.48e-05	6.76e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CREB1—sarcoma	1.48e-05	6.76e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FOXO1—sarcoma	1.48e-05	6.75e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PDGFRB—sarcoma	1.48e-05	6.74e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KRAS—sarcoma	1.47e-05	6.72e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KRAS—sarcoma	1.47e-05	6.72e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KRAS—sarcoma	1.46e-05	6.67e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PDGFRA—sarcoma	1.45e-05	6.63e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—sarcoma	1.45e-05	6.63e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—sarcoma	1.45e-05	6.63e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—HRAS—sarcoma	1.44e-05	6.56e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FOXO1—sarcoma	1.43e-05	6.53e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FOXO1—sarcoma	1.43e-05	6.53e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PDGFRB—sarcoma	1.43e-05	6.52e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PDGFRB—sarcoma	1.43e-05	6.52e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KRAS—sarcoma	1.41e-05	6.45e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KRAS—sarcoma	1.41e-05	6.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PDGFRA—sarcoma	1.41e-05	6.42e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PDGFRA—sarcoma	1.41e-05	6.42e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—HRAS—sarcoma	1.39e-05	6.34e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—HRAS—sarcoma	1.39e-05	6.34e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MDM2—sarcoma	1.37e-05	6.26e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—MYC—sarcoma	1.37e-05	6.23e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL2—sarcoma	1.34e-05	6.13e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MDM2—sarcoma	1.33e-05	6.06e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MDM2—sarcoma	1.33e-05	6.06e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL2—sarcoma	1.3e-05	5.93e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL2—sarcoma	1.3e-05	5.93e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HRAS—sarcoma	1.29e-05	5.9e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MDM2—sarcoma	1.27e-05	5.8e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MDM2—sarcoma	1.27e-05	5.78e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HRAS—sarcoma	1.25e-05	5.71e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HRAS—sarcoma	1.25e-05	5.71e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HRAS—sarcoma	1.24e-05	5.67e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL2—sarcoma	1.23e-05	5.6e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MDM2—sarcoma	1.23e-05	5.6e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MDM2—sarcoma	1.23e-05	5.6e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KDR—sarcoma	1.22e-05	5.58e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HRAS—sarcoma	1.2e-05	5.48e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HRAS—sarcoma	1.2e-05	5.48e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—JUN—sarcoma	1.19e-05	5.45e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL2—sarcoma	1.19e-05	5.41e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL2—sarcoma	1.19e-05	5.41e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CTNNB1—sarcoma	1.18e-05	5.4e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KDR—sarcoma	1.18e-05	5.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KDR—sarcoma	1.18e-05	5.4e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—JUN—sarcoma	1.15e-05	5.27e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—JUN—sarcoma	1.15e-05	5.27e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CTNNB1—sarcoma	1.15e-05	5.23e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CTNNB1—sarcoma	1.15e-05	5.23e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL2—sarcoma	1.14e-05	5.18e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KIT—sarcoma	1.13e-05	5.14e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—NRAS—sarcoma	1.13e-05	5.14e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—sarcoma	1.11e-05	5.05e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—JUN—sarcoma	1.11e-05	5.04e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CTNNB1—sarcoma	1.1e-05	5e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CTNNB1—sarcoma	1.09e-05	4.99e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KIT—sarcoma	1.09e-05	4.98e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KIT—sarcoma	1.09e-05	4.98e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—NRAS—sarcoma	1.09e-05	4.97e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—NRAS—sarcoma	1.09e-05	4.97e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CREB1—sarcoma	1.07e-05	4.9e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—SRC—sarcoma	1.07e-05	4.88e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CTNNB1—sarcoma	1.06e-05	4.83e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CTNNB1—sarcoma	1.06e-05	4.83e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CREB1—sarcoma	1.04e-05	4.74e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CREB1—sarcoma	1.04e-05	4.74e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—SRC—sarcoma	1.04e-05	4.72e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—SRC—sarcoma	1.04e-05	4.72e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—sarcoma	1.03e-05	4.7e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—sarcoma	1.03e-05	4.69e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—sarcoma	9.97e-06	4.55e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—sarcoma	9.97e-06	4.55e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—sarcoma	9.94e-06	4.53e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—sarcoma	9.94e-06	4.53e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SRC—sarcoma	9.92e-06	4.52e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—SRC—sarcoma	9.89e-06	4.51e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—sarcoma	9.7e-06	4.43e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—sarcoma	9.66e-06	4.41e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—SRC—sarcoma	9.56e-06	4.36e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—SRC—sarcoma	9.56e-06	4.36e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—sarcoma	9.54e-06	4.35e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—sarcoma	9.51e-06	4.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—sarcoma	9.39e-06	4.28e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—sarcoma	9.39e-06	4.28e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—sarcoma	9.39e-06	4.28e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—sarcoma	9.2e-06	4.2e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—sarcoma	9.2e-06	4.2e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—sarcoma	9.08e-06	4.14e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—sarcoma	9.08e-06	4.14e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—sarcoma	8.89e-06	4.05e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—sarcoma	8.88e-06	4.05e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—sarcoma	8.87e-06	4.04e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—sarcoma	8.86e-06	4.04e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—sarcoma	8.69e-06	3.96e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—sarcoma	8.67e-06	3.95e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—sarcoma	8.59e-06	3.92e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—sarcoma	8.59e-06	3.92e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—sarcoma	8.58e-06	3.91e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—sarcoma	8.58e-06	3.91e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—sarcoma	8.57e-06	3.91e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—sarcoma	8.57e-06	3.91e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—sarcoma	8.38e-06	3.82e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—sarcoma	8.38e-06	3.82e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—sarcoma	8.25e-06	3.76e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—sarcoma	8.21e-06	3.75e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—sarcoma	8.19e-06	3.73e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—sarcoma	7.98e-06	3.64e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—sarcoma	7.98e-06	3.64e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—sarcoma	7.93e-06	3.62e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—sarcoma	7.92e-06	3.61e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—sarcoma	7.92e-06	3.61e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—sarcoma	7.73e-06	3.53e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—sarcoma	7.72e-06	3.52e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—sarcoma	7.68e-06	3.5e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—sarcoma	7.68e-06	3.5e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—sarcoma	7.66e-06	3.49e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—sarcoma	7.54e-06	3.44e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—sarcoma	7.48e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—sarcoma	7.48e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—sarcoma	7.47e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—sarcoma	7.47e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—sarcoma	7.41e-06	3.38e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—sarcoma	7.41e-06	3.38e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—sarcoma	7.3e-06	3.33e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—sarcoma	7.29e-06	3.33e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—sarcoma	7.29e-06	3.33e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—sarcoma	6.98e-06	3.18e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—sarcoma	6.96e-06	3.17e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SRC—sarcoma	6.92e-06	3.16e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—sarcoma	6.74e-06	3.08e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—sarcoma	6.73e-06	3.07e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—sarcoma	6.73e-06	3.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SRC—sarcoma	6.7e-06	3.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SRC—sarcoma	6.7e-06	3.05e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—sarcoma	6.66e-06	3.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—sarcoma	6.52e-06	2.98e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—sarcoma	6.52e-06	2.98e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—sarcoma	6.44e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—sarcoma	6.44e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—sarcoma	6.2e-06	2.83e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—sarcoma	6.07e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—sarcoma	6e-06	2.74e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—sarcoma	6e-06	2.74e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—sarcoma	5.87e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—sarcoma	5.87e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—sarcoma	5.73e-06	2.61e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—sarcoma	5.55e-06	2.53e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—sarcoma	5.55e-06	2.53e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—sarcoma	5.1e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—sarcoma	4.93e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—sarcoma	4.93e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—sarcoma	4.87e-06	2.22e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—sarcoma	4.71e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—sarcoma	4.71e-06	2.15e-05	CbGpPWpGaD
